Back to SYRE
ADAGE CAPITAL PARTNERS GP, L.L.C. → SYRE
ADAGE CAPITAL PARTNERS GP, L.L.C. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
2
Latest value
$157.4M
Q3 2026
Peak value
$157.4M
First seen
Q2 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2026 | $152.9M |
| Q3 2026 | $157.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $157.4M | 1.77M | — | — |
| Q2 2026 | $152.9M | 1.72M | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$383.5M
$377.5M
$348.1M
$336.7M